Trial Profile
A prospective trial of intradetrusor onabotulinumtoxinA injections assessing long-term outcomes and adherence to treatment in patients with refractory neurogenic detrusor overactivity.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 30 Jun 2016
Price :
$35
*
At a glance
- Drugs Botulinum-Toxin-A (Primary)
- Indications Overactive bladder
- Focus Therapeutic Use
- 30 Jun 2016 New trial record